Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 |
filingDate |
2003-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_338deecfdbe32e037c885737c91fec32 |
publicationDate |
2003-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2003165565-A1 |
titleOfInvention |
Chrono delivery formulations and method of use thereof |
abstract |
A dosage formulation for once daily administration prior to sleeping is described that provides an initial delay in pharmaceutical release followed by controlled release of the pharmaceutical. There is also provided a method for preparing a time specific delayed, controlled release formulation of dosage, which method includes coating a single pellet with at least one dosage layer, which is coated by at least one seal coat and at least one outer rate controlling layer of a water soluble polymer coat. The dosage formulation of this invention provides substantially a drug free interval of about 0 to 5 hours followed by a drug delivery interval at a rate permitting bioavailability thereof for up to about 24 hours following oral administration. A method of using the formulations of the present invention for the treatment of early morning pathologies is also described. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10172804-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11311490-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11298325-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10874620-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9616071-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10117869-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015064249-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114129541-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10537570-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10537588-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10071162-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007269506-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007016948-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11185590-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10639305-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10398705-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010151017-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11413285-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10653633-B2 |
priorityDate |
2000-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |